Author:
Li Haoran,Pan Tongtong,Gao Lingjia,Ding Rongxiu,Yu Yanwen,Ma Mengchen,Wang Yajiao,Jin Shengnan,Chen Yongping,Ding Chunming,Xu Liang
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference48 articles.
1. Burden of illness and economic impact of nonalcoholic steatohepatitis (NASH) in the United States according to the presence of obesity;Younossi;Hepatology,2021
2. Nonalcoholic steatohepatitis: a review;Sheka;JAMA,2020
3. An update on the chemokine system in the development of NAFLD;Nagata;Medicina (Kaunas),2022
4. Macrophage functional diversity in NAFLD-more than inflammation;Barreby;Nat Rev Endocrinol,2022
5. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention;Tacke;Ann Transl Med,2021